{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:54:00Z","timestamp":1791338040188,"version":"4.3.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100015015","name":"Government of South Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["NIDDK-R01DK101500"],"award-info":[{"award-number":["NIDDK-R01DK101500"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K23DK122131"],"award-info":[{"award-number":["K23DK122131"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015340","name":"Bayer Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015340","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002822","name":"Central South University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002822","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011790","name":"Xiangya Hospital, Central South University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011790","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1053\/j.ajkd.2021.02.336","type":"journal-article","created":{"date-parts":[[2021,4,24]],"date-time":"2021-04-24T05:40:47Z","timestamp":1619242847000},"page":"700-708.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Mortality, Kidney Failure, and Hospitalization Among Medicare Beneficiaries With CKD and Pulmonary Hypertension"],"prefix":"10.1053","volume":"78","author":[{"given":"Sankar D.","family":"Navaneethan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl P.","family":"Walther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Parker","family":"Gregg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shweta","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang C.","family":"Winkelmayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Nambi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingbo","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25 suppl","key":"10.1053\/j.ajkd.2021.02.336_bib1","doi-asserted-by":"crossref","first-page":"D42","DOI":"10.1016\/j.jacc.2013.10.032","article-title":"Definitions and diagnosis of pulmonary hypertension","volume":"62","author":"Hoeper","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1053\/j.ajkd.2021.02.336_bib2","doi-asserted-by":"crossref","first-page":"1801913","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"24","author":"Simonneau","year":"2019","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1053\/j.ajkd.2021.02.336_bib3","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1681\/ASN.2014111111","article-title":"Prevalence, predictors, and outcomes of pulmonary hypertension in CKD","volume":"27","author":"Navaneethan","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2021.02.336_bib4","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/ki.2015.27","article-title":"High estimated pulmonary artery systolic pressure predicts adverse cardiovascular outcomes in stage 2-4 chronic kidney disease","volume":"88","author":"Bolignano","year":"2015","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.ajkd.2021.02.336_bib5","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2215\/CJN.10191013","article-title":"Presence and outcomes of kidney disease in patients with pulmonary hypertension","volume":"9","author":"Navaneethan","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2021.02.336_bib6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1053\/j.ajkd.2017.11.018","article-title":"Pulmonary hypertension, mortality, and cardiovascular disease in CKD and ESRD patients: a systematic review and meta-analysis","volume":"72","author":"Tang","year":"2018","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1053\/j.ajkd.2021.02.336_bib7","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.jacc.2020.06.069","article-title":"Pulmonary Hypertension in HFpEF and HFrEF: JACC Review Topic of the Week","volume":"76","author":"Guazzi","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"13","key":"10.1053\/j.ajkd.2021.02.336_bib8","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1016\/j.jacc.2017.01.051","article-title":"Pulmonary Hypertension in Heart Failure: Pathophysiology, Pathobiology, and Emerging Clinical Perspectives","volume":"69","author":"Guazzi","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1053\/j.ajkd.2021.02.336_bib9","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.2215\/CJN.01960408","article-title":"Pulmonary hypertension, right ventricular failure, and kidney: different from left ventricular failure?","volume":"3","author":"Schrier","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2021.02.336_bib10","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1053\/j.ajkd.2016.03.415","article-title":"Obstructive and restrictive lung function measures and CKD: National Health and Nutrition Examination Survey (NHANES) 2007-2012","volume":"68","author":"Navaneethan","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1053\/j.ajkd.2021.02.336_bib11","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1093\/ndt\/gfn751","article-title":"Systemic inflammation is associated with pulmonary hypertension in patients undergoing haemodialysis","volume":"24","author":"Yu","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1053\/j.ajkd.2021.02.336_bib12","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1681\/ASN.2016030317","article-title":"Arterial and cellular inflammation in patients with CKD","volume":"28","author":"Bernelot Moens","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2021.02.336_bib13","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/ki.1995.18","article-title":"Excess PTH in CRF induces pulmonary calcification, pulmonary hypertension and right ventricular hypertrophy","volume":"47","author":"Akmal","year":"1995","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.ajkd.2021.02.336_bib14","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1378\/chest.124.6.2093","article-title":"Pulmonary hypertension in patients with chronic renal failure: role of parathyroid hormone and pulmonary artery calcifications","volume":"124","author":"Amin","year":"2003","journal-title":"Chest"},{"issue":"5","key":"10.1053\/j.ajkd.2021.02.336_bib15","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1053\/j.ajkd.2019.08.027","article-title":"Pulmonary hypertension subtypes and mortality in CKD","volume":"75","author":"Edmonston","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1053\/j.ajkd.2021.02.336_bib16","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1053\/j.ajkd.2019.12.005","article-title":"Diagnosis and management of pulmonary hypertension in patients with CKD","volume":"75","author":"Walther","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.ajkd.2021.02.336_bib17","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1086\/690018","article-title":"Kidney dysfunction in patients with pulmonary arterial hypertension","volume":"7","author":"Nickel","year":"2017","journal-title":"Pulm Circ"},{"issue":"2","key":"10.1053\/j.ajkd.2021.02.336_bib18","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1164\/rccm.201903-0656CI","article-title":"Beyond the lungs: systemic manifestations of pulmonary arterial hypertension","volume":"201","author":"Nickel","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1053\/j.ajkd.2021.02.336_bib19","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/nrneph.2012.197","article-title":"Subclinical AKI\u2014an emerging syndrome with important consequences","volume":"8","author":"Haase","year":"2012","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2021.02.336_bib20","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.chest.2018.11.030","article-title":"Therapy for pulmonary\u00a0arterial hypertension in adults: update of the CHEST Guideline and Expert Panel Report","volume":"155","author":"Klinger","year":"2019","journal-title":"Chest"},{"issue":"15","key":"10.1053\/j.ajkd.2021.02.336_bib21","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"24","key":"10.1053\/j.ajkd.2021.02.336_bib22","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1053\/j.ajkd.2021.02.336_bib23","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1253\/circj.CJ-20-0341","article-title":"Dapagliflozin influences ventricular hemodynamics and exercise-induced pulmonary hypertension in type 2 diabetes patients\u2014a randomized controlled trial","volume":"84","author":"Kayano","year":"2020","journal-title":"Circ J"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638621005709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638621005709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T13:54:13Z","timestamp":1778680453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638621005709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0272638621005709"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2021.02.336","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mortality, Kidney Failure, and Hospitalization Among Medicare Beneficiaries With CKD and Pulmonary Hypertension","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2021.02.336","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc. This is a US Government Work. There are no restrictions on its use.","name":"copyright","label":"Copyright"}]}}